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Three Clostridium botulinum type E strains were sequenced for the botulinum neurotoxin (BoNT) gene
cluster, and 11 type E strains, representing a wide biodiversity, were sequenced for the bont/E gene. The total
length of the BoNT/E gene cluster was 12,908 bp, and a novel gene (partial) designated orfx3, together with the
complete orfx2 gene, was identified in the three type E strains for the first time. Apart from orfx3, the structure
and organization of the neurotoxin gene cluster of the three strains were identical to those of previously
published ones. Only minor differences (<3%) in the nucleotide sequences of the gene cluster components were
observed among the three strains and the published BoNT/E-producing clostridia. The orfx3, orfx2, orfx1, and
p47 gene sequences of the three type E strains shared homologies of 81%, 67 to 76%, 78 to 79%, and 79 to 85%,
respectively, with published sequences for type A1 and A2 C. botulinum. Analysis of bont/E from the 14 type E
strains and 19 previously published BoNT/E-producing clostridia revealed six neurotoxin subtypes, with a new
distinct subtype consisting of three Finnish isolates alone. The amino acid sequence of the subtype E6
neurotoxin differed 3 to 6% from the other subtypes, suggesting that these subtype E6 neurotoxins may possess
specific antigenic or functional properties.
Clostridium botulinum strains produce one or two of the
lethal botulinum neurotoxins (BoNTs) designated A to G ac-
cording to antigenic properties. These toxins are produced as a
progenitor complex consisting of BoNT, hemagglutinin (HA),
nontoxic non-HA (NTNH), and probably other uncharacter-
ized components, such as P47 and OrfX (14, 15). The genes
encoding these proteins are linked as a cluster and vary in
composition and structure among different serotypes and
strains. In general, the ntnh and bont genes are located con-
jointly and arranged in the downstream region of the gene
cluster, whereas the upstream regions vary between different
types and subtypes of C. botulinum (15).
C. botulinum type E predominates in aquatic environments.
It differs from the terrestrial toxinotypes of C. botulinum in the
arrangement of the neurotoxin gene cluster. Kubota et al.
showed that in C. botulinum strain Iwanai, the orfx2, orfx1, and
p47 genes are arranged sequentially in the upstream region of
the type E neurotoxin gene cluster (19). The partial orfx2 (676
bp) was found in the distal upstream region in the same ori-
entation as orfx1, whereas p47 was located immediately up-
stream of ntnh and had the opposite orientation to orfx2 and
orfx1. The type E neurotoxin-producing Clostridium butyricum
strain BL6340 was further shown to be identical to C. botuli-
num Iwanai in toxin gene arrangement (19). To date, no more
sequences of type E neurotoxin gene clusters are available, and
the sequences of the complete orfx2 gene and the further
upstream region of orfx2 in type E strains are unknown. Type
A2 and F strains have orfx2, orfx1, and p47 genes similar to
those of type E but with a regulator gene, botR, located be-
tween the orfx1 and p47 genes (15). Recently, a new gene,
orfx3, in addition to the complete orfx2 gene, was identified in
types A1 and A2 (4).
The nucleotide sequence of bont/E has been published for
36 strains (11, 22, 28, 30). BoNTs are composed of a light chain
(50 kDa) and a heavy chain (100 kDa), linked by a disulfide
bond. BoNTs produced by different types of C. botulinum
share homologies in sequence and structure (20, 23). The light
chain is a metalloprotease, while the C- and N-terminal halves
of the heavy chain are associated with neurospecific binding
and translocation into the nerve cell cytosol, respectively (14).
Any variation in amino acid sequence in these functional do-
mains is sufficient to influence the structure, function, and
antigenic properties of the BoNT complex (18, 20, 25). Based
on amino acid sequences of the neurotoxin, three type E C.
botulinum and 13 neurotoxigenic C. butyricum strains were
classified into three subtypes (25), and 23 C. botulinum and 13
C. butyricum strains were later classified into five subtypes
based on the nucleotide sequences of the bont/E gene (11).
In this study, three C. botulinum type E strains isolated in
Finland, Germany, and the United States were chosen for
sequencing the neurotoxin gene cluster. Furthermore, bont/E
genes were sequenced for 11 strains of mainly Finnish origin.
The neurotoxin gene cluster was composed of the bont/E, ntnh,
p47, orfx1, orfx2, and orfx3 genes. The complete orfx2 and
partial orfx3 genes are reported for the first time in C. botuli-
num type E. Based on nucleotide sequences, bont/E genes in
the currently sequenced and previously published C. botulinum
strains and other BoNT/E-producing clostridia were classified
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TABLE 1. Primers used for sequencing C. botulinum type E strains
Gene Primer Sequence Startsite
Analysis used for sequence identification
for straina:
K35 K81 31-2570 Otherb
orfx3 orfx2E-r6 TTGCAAAAGCAAATCCACCT 265 S S S
orfx2E-f7 TCCTAAAAGCAAGGGTGATGA 810 S S S
orfx2E-r7 CGAATTCATCACCCTTGCTT 835 S S S
orfx3E-r1 TTCCATGTGATTTCAGAAACTG A, S A, S A, S
orfx2 orfx2E-f1 TGGAAAGAAACAATTTTAAAAGATTCA 34 A, S
orfx2E-r1 TGAATGAGTACCGTCTGAATTAGG 330 A, S
orfx2E-f2 TTAATCCTTGCTTGGTTTAAAGA 415 A, S A, S A, S
orfx2E-r2 TCTGCACCCGTAGTCATTTG 674 A, S A, S A, S
orfx2E-f3 CAATGAGGACATTTATCCTGGAG 921 A, S A, S A, S
orfx2E-r3 CCATAGCCATAGCTGCAAAAG 1177 S S S
orfx3E-f1n TGGCAACAAGTAGTGGGTGT 1498 S S S
orfx2E-r4 GGTAACGTCACCAGATTCCTC 1614 S A, S A, S
orfx2E-f5 TGGTTTGATATCCCAAAATGG 1896 S S S
orfx2E-r5 CCATTTTGGGATATCAAACCA 1916 S S S
orfx1 orfx1E-f1 TGGATCAATTCATTTGGAAAAA 57 A, S
orfx1E-f1n GGGATGGAATTGAAACAAGC 3 S S
orfx1E-r1 TCCCTTTTTAAAGCAACCAAA 221 A, S
orfx1E-f2 AGGGATTATTTAAGTTTATCTTTGTCA 217 A, S S S
orfx1E-r2 AGAATTCCATTTTTAGTTATCCTTTTT 359 A, S S S
p47 p47E-f1 GAATACCTATGGTTGGGATATCGT 3 A, S A, S A, S
p47E-r1 TTCATCTTCTTCATATAATTTTCCAC 402 A, S A, S A, S
p47E-f2 GGTCATAGTTTCAGATCTTAGTGGAA 357 A, S S
p47E-r2 TGCTGCTACTTTAATCCCATACC 825 A, S S
p47E-f3 AAAAATACATTAAATTGGTATGGGATT 787 A, S S S
p47E-r3 TTTGCTAATTCAAAAGCTAAGGA 1139 A, S A, S A, S
ntnh ntnhE-f1 TGGTAATTTAAATATTGATTCTCCTG 12 A, S A, S A, S
ntnhE-r1 AAAAGTTTATAATCAATTCCTCCTGA 728 A, S A, S A, S
ntnhE-1L GCAGAAAGTGGAATGGGAAC 472 S S S
ntnhE-1R CATGGTTCCCATTCCACTTT 495 S S S
ntnhE-r2 AAATAATTTACTGGTAATGGTGTGG 1409 A, S S S
ntnhE-2L TTCAAATCATGATGCCAGAAA 929 S S S
ntnhE-2R TTTCTGGCATCATGATTTGAA 949 S S S
ntnhE-f3 GCTAAGGAAATTAATACTACCACACCA 1366 A, S S S
ntnhE-r3 TTCAAAAACACACATAGCAGCA 2169 A, S A, S A, S
ntnhE-3L CCATGGATTGGTAGAGCATT 1663 S S S
ntnhE-3R TTGTGTCCACCATTGATCTAAA 1920 S S S
ntnhE-f4 TGCTGCTATGTGTGTTTTTGA 2148 A, S A, S A, S
ntnhE-r4 TTTCTTTAATATCTTCATTTGCAACAA 2875 A, S A, S A, S
ntnhE-4L TTGGAGATACATCCGGTAAAAA 2447 S S S
ntnhE-4R AGCCCCAGTTAAATGTATTGC 2544 S S S
ntnhE-f5 TTGTTGCAAATGAAGATATTAAAGAAA 2849 A, S A, S A, S
ntnhE-r5 TTTTGGCATATACAGCATCTCC 3525 A, S S S
ntnhE-5L TGTTCAAAAATGGGATGAGG 3210 S S S A, S
ntnhE-5R CCTCATCCCATTTTTGAACA 3229 S S S
bont/E bontE-f1 CAGGCGGTTGTCAAGAATTT 68 A, S A, S A S
bontE-r1 TCCGCTAGCATCTTTATCTAATCC 945 A, S A, S A, S S
bontE-1L ATAATGGGAGCAGAGCCTGA 448 S S S S
bontE-1R ATCAGGCTCTGCTCCCATTA 468 S S S S
bontE-r2 TAATGCTGCTTGCACAGGTT 1713 A, S A, S A, S S
bontE-2L TTTTTGTGGCTTCCGAGAAT 1304 S S S S
bontE-2R ATTCTCGGAAGCCACAAAAA 1323 S S S S
bontE-f3 AACCTGTGCAAGCAGCATTA 1694 A, S A, S A, S A, S
bontE-r3 TCTGTATAAGAAGAAAGCTTAAAAGGA 2495 A, S A, S A, S A, S
bontE-3L TGAACCCGAGCTTTTAATTCC 1908 S S S S
bontE-3R GGAATTAAAAGCTCGGGTTCA 1928 S S S S
bontE-f4 TCTTGGGAGAGAGTCAGCAAG 2408 A, S A, S A, S S
bontE-4L GACATTGCAAGATAATGCAGGA 2883 S S S S
bontE-4R TGCATTATCTTGCAATGTCCA 2901 S S S S
bontE-f5 AAGAATTAGATGAAACAGAAATTCAAA 3155 A, S S A, S S
bontE-r5 CTTGCCATCCATGTTCTTCA 3751 A, S A, S
bontE-5R TGGAATTTATGACTTTAGCCGTTTA 3793 A, S A, S A, S A
a A, amplification; S, sequencing.
b Other strains included all tested type E strains, except K35, K81, and 31-2570.
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into six subtypes. A previously unidentified subtype consisted
of three Finnish C. botulinum type E strains.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. A total of 14 C. botulinum
type E strains were analyzed in this study. Strains K3, K8, K14, K15, K35, K36,
FIG. 1. Schematic representation of the neurotoxin gene cluster in
Clostridium botulinum type E, A1, and A2 strains. The gene orientation
is shown by arrows. Only orfx3 in the type E gene cluster is a partial
gene. Type A1 and A2 neurotoxin gene clusters are derived from C.
botulinum A1 strain NCTC 2916 (GenBank accession numbers
AY497357, Y14238, and X52066) and Kyoto-F (accession numbers
AY497358, AB004778, X96493, X87974, and X73423).
TABLE 2. Sequences for comparison of BoNT/E gene clusters among C. botulinum and C. butyricum strains
Accession no. Species Strain Gene(s) Referencea
AM695752 C. botulinum type E K35 orfx3 through bont/E This study
AM695753 C. botulinum type E K81 orfx3 through bont/E This study
AM695754 C. botulinum type E 31-2570 orfx3 through bont/E This study
AM695755 C. botulinum type E K3 bont/E This study
AM695756 C. botulinum type E K8 bont/E This study
AM695757 C. botulinum type E K14 bont/E This study
AM695758 C. botulinum type E K15 bont/E This study
AM695759 C. botulinum type E K36 bont/E This study
AM695760 C. botulinum type E K44 bont/E This study
AM695761 C. botulinum type E K51 bont/E This study
AM695762 C. botulinum type E K101 bont/E This study
AM695763 C. botulinum type E K117 bont/E This study
AM695764 C. botulinum type E K119 bont/E This study
AM695765 C. botulinum type E S16 bont/E This study
X62089 C. botulinum type E Beluga bont/E 22
X62683 C. botulinum type E NCTC 11219 bont/E 30
AB082519 C. botulinum type E 35396 bont/E NA
EF028403 C. botulinum type E E185 bont/E 11
EF028404 C. botulinum type E E544 bont/E 11
X62088 C. butyricum ATCC 43755 bont/E 22
AB037704 C. butyricum LCL155 bont/E 28
AB037705 C. butyricum KZ1899 bont/E 28
AB037706 C. butyricum KZ1897 bont/E 28
AB037707 C. butyricum KZ1898 bont/E 28
AB037708 C. butyricum KZ1886 bont/E 28
AB037709 C. butyricum KZ1887 bont/E 28
AB037710 C. butyricum KZ1889 bont/E 28
AB037711 C. butyricum KZ1890 bont/E 28
AB037712 C. butyricum KZ1891 bont/E 28
AB037713 C. butyricum LCL063 bont/E 28
AB037714 C. butyricum LCL095 bont/E 28
AB039264 C. butyricum BL6340 bont/E 28
AB088207 C. butyricum BL5262 bont/E NA
D12697 C. botulinum type E Mashike ntnh 9
D88418 C. botulinum type E Iwanai p47, orfx1, orfx2 19
U70780 C. botulinum type E Alaska p47 (p48) 21
D12739 C. butyricum BL6340 ntnh 7
D88419 C. butyricum BL6340 p47 19
X96493 C. botulinum type A Kyoto-F p47 5
AB004778 C. botulinum type A Kyoto-F orfx1 19
AY497357 C. botulinum type A NCTC 2916 p47, orfx1, orfx2, orfx3 4
AY497358 C. botulinum type A Kyoto-F orfx2, orfx3 4
DQ310546 C. botulinum type A Mascarpone p47, orfx1, orfx2 6
a NA, no reference available.
TABLE 3. Open reading frames in the neurotoxin gene cluster of
C. botulinum type E strains K35, K81, and 31-2570
Gene Positions
Sequence length Avg GC content (%)
Nucleotide Aminoacid K35 K81 31-2570
orfx3
(partial)
1 to 1355 1,355 451 28.56 28.49 28.49
orfx2 1387 to 3633 2,247 748 27.46 27.55 27.55
orfx1 3647 to 4081 435 144 19.77 19.77 19.77
p47 4368 to 5618 1,251 416 23.34 23.42 23.42
ntnh 5634 to 9125 3,492 1,163 20.90 21.08 21.11
bont/E 9150 to 12908 3,759 1,252 24.55 24.85 24.85
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K44, K51, K117, and K119 were Finnish fish isolates, while strain S16 was
isolated from sea sediment in Finland. Strains K81 and K101 were German fish
isolates. Strain 31-2570 of an unknown source was isolated in the United States.
Strains K35, K81, and 31-2570 were sequenced for the entire type E neurotoxin
gene cluster. The other 11 strains were sequenced for the bont/E gene. All
strains, apart from 31-2570, have been isolated in our laboratory and were
selected for this study based on the wide geographical and genetic diversity
revealed by pulsed-field gel electrophoresis (10), randomly amplified polymor-
phic DNA (13), and amplified fragment length polymorphism (16) analyses. Egg
yolk agar plates were used to subculture these strains and confirm their purity. A
single typical colony was picked and inoculated into 10 ml of anaerobic tryptone-
peptone-glucose-yeast extract (Difco, Detroit, MI) broth. All cultures were in-
cubated overnight at 30°C under anaerobic conditions.
PCR amplification. Genomic DNA was extracted from C. botulinum cultures
as described by Keto-Timonen et al. (16). All primers for amplification and
sequencing are listed in Table 1.
When the genes corresponding to previously published ones were being se-
quenced, PCR was applied to amplify suitable DNA fragments using the primers
targeted to the published genes (9, 19, 30). To consecutively sequence the whole
gene cluster, all adjacent fragments were amplified in an overlapping fashion.
For sequencing the region upstream of the known genes, inverse PCR was
used to amplify the unknown fragment with primers orfx1E-r1 and orfx2E-f2 in
the K35 strain (24). The genomic DNA (27 g) was cut with restriction enzyme
HindIII (New England Biolabs, Inc., Ipswich, MA) at 37°C overnight and then
ligated with T4 DNA ligase (New England Biolabs, Inc.) to form circular DNA
at a DNA concentration of 3 ng/l. The circular DNA was used as a template
at a concentration of 2.5 ng/l (26). After the upstream region of the orfx2 gene
in K35 was sequenced, the primer orfx2E-r4 was designed and used in combi-
nation with orfx2E-f2 to amplify the upstream region of the neurotoxin gene
cluster in strains K81 and 31-2570.
In sequencing the previously unidentified upstream region of the gene cluster,
primers targeted to the consensus sequence of orfx3 from NCTC 2916 and
Kyoto-F (4) were successfully used. This method was considered justified since
high similarities were observed in the nucleotide sequences and arrangements of
the orfx2, orfx1, and p47 genes between the type E strains sequenced here and the
previously published type A strains NCTC 2916 and Kyoto-F (4).
The PCRs were conducted using standard protocols (24). Amplification con-
ditions consisted of 30 cycles of denaturation at 95°C for 30 s, annealing at 55°C
for 30 s, and polymerization at 72°C for 80 s (for 4 min if the fragment was 2 kb
or more), followed by a final extension at 72°C for 3 min (for 10 min if the
fragment was 2 kb or more). Titanium Taq DNA polymerase (Clontech Labo-
ratories, Inc., Mountain View, CA) was used in all PCRs. Amplification was
performed with a PTC-200 thermal cycler (MJ Research, Watertown, MA).
DNA sequencing. Template DNA was purified from PCR products using a
QIAquick PCR purification kit (Qiagen GmbH, Hilden, Germany) or a Montage
PCR96 cleanup kit (Millipore Corp., Billerica, MA). Sequencing PCR was con-
ducted using an ABI BigDye Terminator 3.1 cycle sequencing kit (Applied
Biosystems, Inc., Foster City, CA) according to the manufacturer’s instructions.
After precipitation with ethanol or purification with an Agencourt CleanSEQ kit
(Agencourt Bioscience Corp., Beverly, MA), the sequencing samples were
loaded onto an ABI 310 genetic analyzer or an ABI 3730 genetic analyzer,
respectively. The former method was used to sequence the entire neurotoxin
gene clusters, and the latter method was used to sequence the 11 neurotoxin
genes for more efficient throughput.
Sequence analysis. The sequences of the entire neurotoxin gene clusters and
bont/E were assembled and aligned by Sequencher software (Gene Codes, Ann
Arbor, MI). Bidirectional sequence information from two independent PCRs
was used, and the sequences were considered final when threefold coverage for
each gene was obtained. Sequences were edited by BioEdit software (v. 7.0.5)
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html), and open reading frames were
predicted manually and via ORF Finder software (http://www.ncbi.nlm.nih.
gov/gorf/gorf.html). Alignment and comparison of two or more sequences
were performed using Align (http://www.ebi.ac.uk/emboss/align/index.html)
or ClustalW software (3).
Type E neurotoxin genes from 33 C. botulinum type E strains, including the 14
genes sequenced in this study and 19 previously published ones, were compared
using ClustalW software (3). The GenBank accession numbers of the previously
published sequences are shown in Table 2.
Nucleotide sequence accession numbers. The sequence data reported in this
paper have been submitted to the EMBL Nucleotide Sequence Database under
accession numbers AM695752 through AM695765 and are listed in Table 2.
RESULTS
Structure and organization of BoNT/E gene cluster in three
type E strains. The neurotoxin gene clusters of C. botulinum
K35, K81, and 31-2570 consisted of six genes and were each
12,908 bp long (Table 3). For the first time, the entire nucle-
otide sequences of orfx2 (2,247 bp) and a partial orfx3 gene
(1,355 bp), located immediately upstream of orfx2 and having
the same orientation as orfx2, were determined for the type E
BoNT gene cluster (Fig. 1). The structures of the neurotoxin
gene clusters in the three C. botulinum strains were identical to
each other and, apart from the novel elements, to published
ones.
K81 and 31-2570 had identical sequences for p47, orfx1,
orfx2, and orfx3. These two strains were also highly similar in
their bont/E and ntnh sequences. K35 differed from the other
two strains in bont/E and orfx2, with 98% and 99.1% identities,
respectively; however, K35 was highly identical to K81 and
31-2570 in the p47, orfx1, and orfx3 gene sequences (Table 4).
Marked differences were observed in the GC content of the six
genes in the bont/E cluster, with orfx1 showing the lowest and
FIG. 2. The bont/E genes from 14 Clostridium botulinum type E
strains sequenced here and the 19 previously published ones were
compared using ClustalW software. Six distinct neurotoxin subtypes
were described and designated E1 to E6. C. botulinum strains fell into
subtypes E1, E2, E3, and E6, while subtypes E4 and E5 consisted of C.
butyricum strains alone. Three Finnish isolates formed a previously
unidentified neurotoxin subtype, E6.
TABLE 4. Identity of BoNT/E gene clusters and member genes
among C. botulinum K35, K81, and 31-2570
Strains
compared
% Identity
Gene
cluster bont/E ntnh p47 orfx1 orfx2 orfx3
K35 and K81 99.1 98.0 99.5 99.9 100 99.1 99.9
K35 and 31-
2570
99.1 98.0 99.6 99.9 100 99.1 99.9
K81 and 31-
2570
99.98 99.97 99.97 100 100 100 100
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the partial orfx3 gene the highest proportions of GC content
(Table 3).
Diversity of type E neurotoxin genes. The bont/E genes from
a total of 33 strains of BoNT/E-producing clostridia were an-
alyzed (Table 2). These strains included the 14 C. botulinum
type E strains of mainly Finnish origin described in this study
and 19 C. botulinum and C. butyricum strains with bont/E
sequences available in GenBank. The 33 strains could be clas-
sified into six subtypes based on the nucleotide sequences of
bont/E (Fig. 2). Five Finnish and four other C. botulinum
strains of diverse origin formed subtype E1. All of these strains
were identical in their bont/E gene sequences, with the excep-
tion of C. botulinum Beluga (GenBank accession number
X62089), which showed a 1% difference. Subtype E2 included
one C. botulinum strain E544 (EF028404) alone, while subtype
E3 included six C. botulinum strains from Finland, Germany,
and the United States. Except for strain 31-2570, the strains in
subtype E3 had 100% identical bont/E genes. All C. butyricum
strains formed subtypes E4 and E5, with E4 including
ATCC 43755 (X62088), BL5262 (AB088207), and BL6340
(AB039264). Subtype E5 was a uniform group containing 11 C.
butyricum strains. A previously unidentified subtype designated
E6 included three C. botulinum strains of Finnish origin. Of
these, K36 and S16 had 100% sequence identity for bont/E.
The homology analysis of the nucleotide and amino acid
sequences of BoNT/E within and between the six subtypes is
shown in Table 5. Strains within a subtype had only 1% differ-
ences in their nucleotide and amino acid sequences, while 1 to
3% and 1 to 5% differences in nucleotide and amino acid
sequences, respectively, were observed between the four sub-
types of C. botulinum. Between the C. botulinum and C.
butyricum subtypes, 2 to 3% and 3 to 6% differences in the
nucleotide and amino acid sequences, respectively, were ob-
served. Moreover, the two C. butyricum subtypes had corre-
sponding differences of 3% and 5% in their nucleotide and
amino acid sequences.
Homology of ntnh and p47. Among C. botulinum type E
strains K35, K81, 31-2570, and Mashike (GenBank accession
number D12697), the ntnh genes were in general 99% homol-
ogous in nucleotide and corresponding amino acid sequences;
however, strains K35 and Mashike shared 98% amino acid
sequence homology for ntnh. Furthermore, the differences be-
tween the four C. botulinum strains and C. butyricum BL6340
TABLE 5. Homology of nucleotide and amino acid sequences for BoNT/E genes from representative strains of each subtype
Strain
% Homology for indicated strain of subtypea:
E6 E3 E1 E2 E4 E5
K35 K36 K81 31-2570 K8 Beluga E544 BL5262 LCL155
nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa
K35 99 99 97 95 98 95 98 96 98 96 98 96 98 96 97 94
K36 98 95 98 96 98 97 98 96 98 96 98 96 97 94
K81 99 99 99 98 99 97 98 97 97 95 97 95
31-2570 99 98 99 97 98 97 97 95 97 95
K8 99 99 99 99 98 97 98 96
Beluga 99 98 98 96 98 96
E544 98 97 97 96
BL5262 97 95
a nt, nucleotide; aa, amino acid.
TABLE 6. Homology of nucleotide and amino acid sequences for the p47 gene and the orfx1 gene among types E and A
neurotoxin-producing clostridia
Strain
% Homologya
C. botulinum type E C.
butyricum
BL6340
C. botulinum type A
K35 K81 31-2570 Iwanai Alaska (p48) NCTC2916 Kyoto-F Mascarpone
nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa nt aa
K35 99 99 99 99 99 99 99 99 98 98 85 81 79 72 80 72
K81 100 100 100 100 100 100 100 100 99 98 85 81 79 72 80 72
31-2570 100 100 100 100 100 100 100 100 99 98 85 81 79 72 80 72
Iwanai 100 100 100 100 100 100 100 100 99 98 85 81 79 72 80 72
Alaska 99 98 85 81 79 72 80 72
BL6340 85 80 79 71 80 71
NCTC 2916 78 72 78 72 78 72 78 72 85 79 87 81
Kyoto-F 79 72 79 72 79 72 79 72 93 89 96 95
Mascarpone 79 72 79 72 79 72 79 72 99 99 93 88
a nt, nucleotide; aa, amino acid. Homologies for the p47 gene sequences are given in the top right portion of the table, whereas those for the orfx1 gene are given
in the lower left portion.
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were 1 to 2% in nucleotide sequences and 2% in amino acid
sequences.
All the BoNT/E-producing clostridia shared a high homol-
ogy in the nucleotide and amino acid sequences for p47. C.
botulinum K35 shared 99% homology in the nucleotide and
amino acid sequences for p47 with K81, 31-2570, Iwanai (ac-
cession number D88418), and Alaska (U70780, previously
named p48), the four strains being identical in p47 sequence.
With C. butyricum BL6340 (D88419), all C. botulinum type E
strains had 98 to 99% and 98% homologies in nucleotide and
amino acid sequences, respectively (Table 6).
The p47 genes in the BoNT/E-producing clostridia were
markedly different from those in C. botulinum type A strains
NCTC 2916 (AY497357), Kyoto-F (X96493), and Mascarpone
(DQ310546). The differences in nucleotide and amino acid
sequences were 15 to 21% and 19 to 29%, respectively
(Table 6).
Homology of orfx1, orfx2, and orfx3. No difference was found
in orfx1 among C. botulinum type E strains K35, K81, 31-2570,
and Iwanai (D88418). However, differences of 21 to 22% and
28% in nucleotide and amino acid sequences, respectively, for
orfx1 were observed among type E, type A1, and type A2
strains (Table 6).
For orfx2, there were only differences of 1% and 2% in the
nucleotide and amino acid sequences, respectively, among the
C. botulinum type E strains (Table 7), while again considerable
differences were observed among strain types E, A1, and A2.
Moreover, for orfx3, high homologies (99 to 100%) of nucle-
otide and amino acid sequences were present among C. botu-
linum type E strains, while homologies of only 81% and 75 to
76% were observed among strain types E, A1, and A2
(Table 7).
Analysis of amino acid sequence of BoNT/E. A total of 149
variable sites were found in the alignment of the BoNT/E
amino acid sequences of seven strains representing the differ-
ent subtypes (Table 8). The variable sites were distributed
mainly in the light chain (37.6%) and the C-terminal half of the
heavy chain (43.0%), while less variation was observed in the
N-terminal half of the heavy chain (19.4%). No variation was
seen in the conserved motifs of the functional domains. Com-
pared with the consensus sequence, the sequences of the C.
butyricum strains forming subtype E5 had maximum variability,
with all their variable residues being within the heavy chain. By
contrast, the C. botulinum K8 sequence had no variation at all.
Sequences of strains within the new subtype E6 had the second
highest variability distributed along the functional domains of
the light chain and the N- and C-terminal halves of the heavy
chain. The number and distribution of variable amino acid
residues for subtype E6 differed markedly from those of the
other subtypes.
DISCUSSION
To our knowledge, we are the first to report partial orfx3 and
complete orfx2 genes in the BoNT type E gene cluster of three
C. botulinum strains. Apart from orfx3, the other components
of the neurotoxin gene cluster were nearly identical to the
published sequences of C. botulinum Iwanai and C. butyricum
BL6340 in composition, size, and organization (19).
In addition to BoNT/E-producing clostridia, orfx1, orfx2,
orfx3, and p47 have been found in some type A1 and A2 strains
(4, 6). These genes show tremendous similarities among type
E, A1, and A2 toxin gene clusters in nucleotide sequence, size,
and gap distance (Fig. 1). An interesting feature of our type E
strains and the A2 strain Mascarpone (6) is the lack of poten-
tial insertion elements detected in the intergenic regions of the
neurotoxin gene cluster of type A1 strain NCTC 2916 and type
A2 strain Kyoto-F (4). The striking similarities, together with
evidence of transposable elements, suggest that gene transfer
and recombination have occurred among type A and E neu-
TABLE 7. Homology of nucleotide and amino acid sequences for the orfx2 gene and the orfx3 gene among types E and A
neurotoxin-producing clostridia
Strain
% Homologya
C. botulinum type E C. botulinum type A
K35 K81 31-2570 Iwanai(partial) NCTC 2916 Kyoto-F
Mascarpone
(partial)
nt aa nt aa nt aa nt aa nt aa nt aa nt aa
K35 99 98 99 98 99 98 67 49 68 49 76 71
K81 99 99 100 100 99 98 68 50 68 50 76 61
31-2570 99 99 100 100 99 98 68 50 68 50 76 61
Iwanai 75 60 76 60 76 60
NCTC 2916 81 76 81 76 81 76 97 96 98 97
Kyoto-F 81 75 81 75 81 75 94 94 100 100
a nt, nucleotide; aa, amino acid. Homologies for the orfx2 gene sequences are given in the top right portion of the table, whereas those for the orfx3 gene are given
in the lower left portion.
TABLE 8. Numbers of variable amino acid residues in BoNT/E
among the representative strains of different subtypes
Location
No. of variable amino acid residues in indicated
strain of serotype:
E1 E2 E3 E4 E5 E6
K8 Beluga E544 31-2570 BL5262 LCL155 K36
Light chain 0 3 1 21 17 0 14
N-terminal half of
heavy chain
0 1 0 0 7 9 12
C-terminal half of
heavy chain
0 4 10 0 9 30 11
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rotoxin-producing clostridia, supporting the theory of gene
transfer playing a role in the evolutionary history of the BoNT
gene cluster (2). It is tempting to speculate that the lack of
insertion elements in our type E strains and strain Mascarpone
(6) indicates that these orfx1-, orfx2-, and orfx3-carrying strains
represent a conserved ancestor in the evolutionary history of
the neurotoxin gene cluster. However, the variable GC content
among the neurotoxin genes, particularly orfx1, orfx2, and
orfx3, undermines this theory and may suggest the emergence
of these genes from a more heterogeneous origin.
We did not detect definite promoters for orfx1, orfx2, and
orfx3 in the three type E strains. Dineen et al. found that in
type A2 strain Kyoto-F, orfx1, orfx2, and orfx3 were transcribed
as a polycistronic transcript from a conserved promoter 1,179
bases upstream of the orfx1 start codon and speculated that the
corresponding gene products had a coordinated role in the
production and expression of the neurotoxin complex (4).
Whether the orfx1, orfx2, and orfx3 genes play a role in the
production of the biologically active BoNT/E complex or
whether these genes have lost their meaning through evolu-
tion, both possibilities warrant further investigation.
Six subtypes of the type E neurotoxin gene were found
among 33 BoNT/E-producing clostridia, based on nucleotide
sequences. Five of the subtypes (E1 through E5) are in agree-
ment with a previous subdivision by Hill et al. based on nucle-
otide sequences (11). While most Finnish C. botulinum strains
fell into two subtypes, E1 and E3, the three Finnish strains
K35, K36, and S16 formed a new subtype, designated E6, based
on their nucleotide sequences. The E6 strains clearly differed
from the other subtypes (by 3 to 6%) in their amino acid
sequences of BoNT/E. Although the overall variation in
BoNT/E sequences seems to be lower than that of, for in-
stance, BoNT/A, this level of amino acid variability has been
shown to affect the antigenic and biological properties of the
neurotoxin (17, 27). Since C. botulinum type E strains are
frequently found in the Baltic Sea region and in Finnish fresh-
waters and have been shown to possess a strikingly high biodi-
versity (10, 13, 16), even more BoNT/E subtypes likely exist
among the Finnish C. botulinum population. Hence, further
investigations of C. botulinum strains are warranted.
In the alignment of the BoNT/E amino acid sequences de-
termined in this study or published previously, we found that
most of the 149 variable sites were distributed mainly along the
catalytic and binding domains. Strains representing different
subtypes showed distinct distributions for the variable amino
acid residues. For example, C. botulinum strain 31-2570 in
subtype E3 showed variation only within its catalytic domain.
In BoNT/E, this domain residing in the light chain specifically
recognizes and cleaves SNAP-25 (synaptosome-associated pro-
tein of 25 kDa), and thus blocks neurotransmission in the
synaptic vesicle (12, 29). However, the highly conserved zinc-
binding motif of HELIHSLH, responsible for protease activity
in the catalytic domain (1, 8, 20), was unchanged in the com-
pared BoNT/E sequences.
As opposed to subtype E3, the subtype E5 strain C.
butyricum LCL155 had all of its variable amino acids within the
heavy chain, most of them in the C-terminal binding domain.
The high variability in this domain results in a variety of sur-
face structures that can act as neurospecific epitopes, confer-
ring a unique antigenicity and binding to receptors in nerve
cells (14, 18, 20). Despite the large number of variable amino
acid residues in the binding domain, the conserved motif YL
THMRD, responsible for receptor binding in BoNT/E (18, 20),
was unaltered in the BoNT/E sequences analyzed.
A relatively low level of variation among the BoNT/E amino
acid sequences was observed in the translocation domain at the
N terminus of the heavy chain. With the exception of one
amino acid shift from Glu to Val (position 637) in C. butyricum
LCL155 (accession number AB037704), no variation was ob-
served in the hydrophobic domain (positions 624 to 645). The
translocation domain is assumed to sense environmental vari-
ations and is essential for the channel formation in the endo-
cytosis vesicle membrane for further translocation into the
nerve cell cytosol (20). Any changes in the hydrophobic do-
main will probably affect the channel structure and impair the
potential spanning function (18, 30).
As discussed above, the strains of the new subtype E6 were
3 to 6% different from the other subtypes in their BoNT/E
amino acid sequences. Although the conserved motifs were not
altered, variation was evenly distributed in all three functional
domains. Tsukamoto et al. reported the neurotoxin of C.
butyricum LCL155 to possess different binding activity, toxicity,
and antigenicity than those of C. botulinum 35396 and C.
butyricum BL5262 (27), with similar levels of amino acid alter-
ations in the heavy chain alone. Considering that subtype E6
had similar levels of alterations along the entire neurotoxin, it
may possess specific antigenic structures and biological prop-
erties.
In conclusion, we sequenced the BoNT/E gene cluster in
three C. botulinum type E strains and the bont/E genes in 11
strains of mainly Finnish origin. The partial orfx3 and complete
orfx2 genes were identified in BoNT/E-producing clostridia for
the first time. The structure and organization of the neurotoxin
gene cluster in type E strains were identical among strains K35,
K81, and 31-2570. Based on the alignment of bont/E gene
sequences, a total of six neurotoxin subtypes were found
among BoNT/E-producing clostridia. A new subtype, E6, con-
sisting of Finnish strains, was observed.
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